Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate [NA]

View source ↗

Summary

Completed clinical trial evaluating topical 0.01% atropine eye drops for slowing myopia progression; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0.01% atropine eye drops (atropine)

Snippet

Sponsor: The Hong Kong Polytechnic University | Conditions: Myopia | NA | Status: COMPLETED | Results posted: 2024-10-16